Alzai Health Corp. ALZI
TSXV · Canada · Technology Services
CAD 0.3000-0.07 (-18.92%)
Market closed· · CAD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · CAD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Toronto, Ontario--(Newsfile Corp. - September 3, 2026) - ALZAI Health Corp. (TSXV: ALZI) (FSE: H2F) ("ALZAI" or the "Company"), a healthcare technology company developing artificial intelligence-driven disease risk identification solutions, is pleased to announce that its common shares are now posted for trading on the Frankfurt Stock Exchange ("FSE") under the symbol H2F.The Frankfurt Stock Exchange is one of Europe's leading securities trading venues, providing access to a broad base of...
Toronto, Ontario--(Newsfile Corp. - August 17, 2026) - Alzai Health Corp. (TSXV: ALZI) (the "Company" or "ALZAI") announces that it has entered into a services agreement dated August 12, 2026 (the "Services Agreement") with Euro Digital Media Ltd. ("Euro Digital") (address: 71-75 Shelton Street, Covent Garden, London, UK WC2H 9JQ) pursuant to which Euro Digital will provide market awareness and digital marketing services to the Company.Under the terms of the Services Agreement, Euro Digital will
Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - August 11, 2026) - ALZAI Health Corp. (TSXV: ALZI) is pleased to announce that it has entered into a Memorandum of Understanding (MOU) with Linus Health, an AI-driven brain health company focused on early detection and proactive intervention. The companies intend to explore opportunities to use their complementary technologies to support earlier identification and assessment of Alzheimer's disease risk and cognitive impairment, as...
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.